- Lobbying
- barr AND laboratories
Lobbying Arrangements Results for 'Barr Laboratories'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Generic Issues - Biogenerics (S.1082; S.623) |
Barr Laboratories, Inc.
|
MCKENNA, LONG & ALDRIDGE | |||
Details Generic biologics |
Barr Laboratories
Generic drug manufacturer |
Cuneo Gilbert & LaDuca | |||
Details Hatch - Waxman reform Monitoring FDA preemption |
Barr Laboratories, Inc.
|
WINSTON & STRAWN LLP | |||
Details Patent reform, Generic Biologies |
Barr Laboratories
|
BROYDRICK & ASSOCIATES | |||
Details Access to Life-Saving Medicine Act dealing with generic alternatives to biological drugs |
Barr Laboratories
Generic drug manufacturer |
Cuneo Gilbert & LaDuca | |||
Details Generic Drug Settlements S.316, Preserve Access to Affordable Generics Act. H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007. H.R. 3161, S. 1859, Funding for the Office of Generi... |
BARR PHARMACEUTICALS, INC (formerly Barr Laboratories, Inc.)
|
Clark Lytle & Geduldig | |||
Details Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007. Advance proposal to ... |
BARR LABORATORIES
|
Forscey & Stinson | |||
Details BIOGENERICS LEGISLATION: PATENT SETTLEMENTS PATENT REFORM: USER FEES |
BARR Laboratories
|
ZUCKERMAN SPAEDER LLP | |||
Details Generic Giologics, HR 1956, S1695, HR1038,HR5629, FDA Reform Patent Reform Generic Drug Settlement Issues Proposed Bilateral Tax Treaty with Croatia |
Barr Laboratories
|
STANTON PARK GROUP | |||
Details Issues related to biomedical research and development; Issues related to pathogen surveillance. |
Bio-Rad Laboratories
|
Forbes-Tate | |||
Details Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and imple... |
American Clinical Laboratory Assn
|
in-house lobbying |